IceCure Medical Ltd. Announces $10 Million Rights Offering to Fund Cryoablation Technology Expansion
IceCure Medical Ltd. has announced a rights offering aimed at raising up to $10 million. The offering will provide holders of the company's ordinary shares as of July 9, 2025, with one subscription right per share. Each right allows the holder to subscribe for 0.1703 of a unit, consisting of an ordinary share and a warrant at $1.00 per unit, or alternatively, a unit with a pre-funded warrant at $0.9999 per unit. The rights must be exercised by July 28, 2025. The company's largest shareholder, Epoch Partner Investments Limited, has committed to participate fully, including any over-subscription, up to $5 million. Proceeds from the offering will be used to repay a $2 million bridge loan from Epoch and for general corporate purposes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IceCure Medical Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: IO18147) on June 25, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。